Prosecution Insights
Last updated: May 29, 2026

Examiner: FONSECA LOPEZ, FRANCINI ALVARENGA

Tech Center 1600 • Art Units: 1645 1682 1685

This examiner grants 25% of resolved cases

Performance Statistics

25.0%
Allow Rate
-35.0% vs TC avg
76
Total Applications
+66.7%
Interview Lift
1276
Avg Prosecution Days
Based on 16 resolved cases, 2023–2026

Rejection Statute Breakdown

13.1%
§101 Eligibility
5.1%
§102 Novelty
70.1%
§103 Obviousness
2.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17876528 BASE CALLING USING MULTIPLE BASE CALLER MODELS Non-Final OA ILLUMINA, INC.
17626782 HYPERSPECTRAL COMPUTER VISION AIDED TIME SERIES FORECASTING FOR EVERY DAY BEST FLAVOR Final Rejection Walmart Apollo, LLC
17872823 DIABETES PREDICTION USING GLUCOSE MEASUREMENTS AND MACHINE LEARNING Non-Final OA DexCom, Inc.
17534841 METHOD AND SYSTEM FOR GENERATING MOLECULAR STRUCTURE OF CHEMICAL COMPOUND Final Rejection Alibaba Group Holding Limited
17302591 PREDICTION OF ENZYMATICALLY CATALYZED CHEMICAL REACTIONS Non-Final OA INTERNATIONAL BUSINESS MACHINES CORPORATION
17644385 NUTRIENT AMOUNT DETERMINATION DEVICE, NUTRIENT AMOUNT DETERMINATION METHOD, AND COMPUTER READABLE MEDIUM STORING NUTRIENT AMOUNT DETERMINATION PROGRAM Final Rejection Rakuten Group, Inc.
17414480 METHODS FOR IDENTIFYING NEOANTIGENS Non-Final OA Dana-Farber Cancer Institute, Inc.
17832252 APPARATUS AND METHOD FOR GENOME SEQUENCE ALIGNMENT ACCELERATION Non-Final OA ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE
17795465 DISEASE DETECTION AND TREATMENT BASED ON PHENYLACETYL GLUTAMINE LEVELS Non-Final OA The Cleveland Clinic Foundation
17286106 METHOD FOR PREDICTING ABSORBANCE CHANGE BY INTERMOLECULAR INTERACTION Final Rejection INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
17857821 SYSTEMS AND METHODS FOR CANCER WHOLE GENOME AND TRANSCRIPTOME SEQUENCING (CWGTS) Non-Final OA Sloan-Kettering Institute for Cancer Research
17487743 NIR SENSOR CALIBRATION METHOD AND SYSTEM Final Rejection CLAAS Selbstfahrende Erntemaschinen GmbH
17553295 System and Method for Control of Sequencing Process Non-Final OA LIFE TECHNOLOGIES CORPORATION
17597489 REAGENT PACK LOAD PLAN OPTIMIZATION METHODS AND SYSTEMS Final Rejection Siemens Healthcare Diagnostics Inc.
17518151 MICROBIOME AND METOBOLOME CLUSTERS TO EVALUATE SKIN HEALTH Final Rejection Johnson & Johnson Consumer Inc.
17523079 ANTI-MICROBIAL PEPTIDES AND METHOD FOR DESIGNING NOVEL ANTI-MICROBIAL PEPTIDES Non-Final OA HEALTH RESEARCH, INC.
17988043 METABOLITE FINGERPRINTING Non-Final OA Zymergen Inc.
17478260 PHARMACEUTICAL COMPOSITION OR FOOD COMPOSITION, AND METHOD FOR ASSESSING EFFECT OF ACTIVE INGREDIENT IN VIVO Final Rejection KARYDO THERAPEUTIX, INC.
17768148 SYSTEM AND COMPUTER IMPLEMENTED METHOD FOR CALCULATING ENERGY DOSES Non-Final OA TERGOS PESQUISA E ENSINO LTDA.
17571774 Diagnosis of Antibiotic Resistance Genes in Clinical Specimens Final Rejection AOS Bioinnovations, LLC
17563103 AI SIMULATION FOR MICROALGAE FERMENTATION Final Rejection Sophie's BioNutrients Pte. Ltd.
17534166 Three-Dimensional Luminescence Imaging Final Rejection PerkinElmer Health Sciences, Inc.
17609204 METHOD AND MEANS FOR OPTIMIZING BIOTECHNOLOGICAL PRODUCTION Final Rejection INSILICO BIOTECHNOLOGY AG
17481243 PREDICTING T CELL EPITOPES USEFUL FOR VACCINATION Final Rejection TRON-Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-
17422726 SYSTEM FOR SIMULATING MOLECULAR INTERACTIONS INVOLVED IN INFLAMMATION Final Rejection Biologische Heilmittel Heel GmbH
17312249 A METHOD TO DETERMINE AGENTS FOR PERSONALIZED USE Non-Final OA Henry Johannes GRETEN

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month